← Back to Search

Orthopedic Device

CEM-Plate and CEM-Cage Devices for Cervical Disc Disorder

N/A
Recruiting
Led By James Lawrence, MD
Research Sponsored by ReVivo Medical, Corp.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Documented diagnosis of cervical spine radiculopathy or myelopathy.
Baseline NDI score ≥30 and/or baseline mJOA score ≤16.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months.
Awards & highlights

Study Summary

This trial is testing a new device for a 2-level ACDF. The device will be evaluated for safety and efficacy in 50 patients.

Who is the study for?
This trial is for adults aged 22-79 with neck pain and spinal issues due to cervical disc disorder, who haven't improved after 6 weeks of non-surgical treatment. Candidates must have specific scores on NDI or mJOA scales, confirmed symptoms by imaging, and be able to consent. Exclusions include prior cervical surgeries at the affected levels, certain bone diseases, severe instability or infection in the spine area, high-dose steroid use, substance abuse history, pregnancy, metal allergies and a BMI over 40.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of CEM-Cage with CEM-Plate in patients needing a two-level anterior cervical discectomy and fusion (ACDF). Fifty participants will undergo ACDF using these devices and will be monitored regularly up to two years post-operation.See study design
What are the potential side effects?
Potential side effects may include typical surgical risks such as infection at the site of implantation, inflammation around the area where devices are placed; allergic reactions if there's an undiagnosed metal allergy; complications from anesthesia; nerve damage that could lead to pain or numbness; difficulty swallowing; bleeding or blood clots.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with nerve or spinal cord issues in my neck.
Select...
My neck disability or arm function scores indicate significant impairment.
Select...
I have neck pain due to disc problems in my spine from C2 to T1.
Select...
My symptoms match the imaging results of my condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fusion
Secondary outcome measures
Device-Related Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Two-Level ACDF with CEM-Plate Anterior Cervical Plating System and CEM-Cage Cervical Interbody System.

Find a Location

Who is running the clinical trial?

ReVivo Medical, Corp.Lead Sponsor
Albany Medical CollegeOTHER
91 Previous Clinical Trials
11,447 Total Patients Enrolled
The Cleveland ClinicOTHER
1,027 Previous Clinical Trials
1,364,228 Total Patients Enrolled

Media Library

CEM-Plate and CEM-Cage (Orthopedic Device) Clinical Trial Eligibility Overview. Trial Name: NCT04883411 — N/A
Cervical Spondylosis Research Study Groups: Treatment
Cervical Spondylosis Clinical Trial 2023: CEM-Plate and CEM-Cage Highlights & Side Effects. Trial Name: NCT04883411 — N/A
CEM-Plate and CEM-Cage (Orthopedic Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04883411 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the research encompass individuals below the age of twenty?

"As specified in the study's inclusion criteria, individuals aged 22 to 79 are eligible to apply. Additionally, there are 7 studies targeting those under 18 and 154 for people over 65 years old."

Answered by AI

How can I participate in this research?

"This medical study is aiming to enroll 50 participants aged 22-79 who are suffering from neck pain. Additional criteria for inclusion include: symptomatic cervical degenerative disc disease at two consecutive levels between C2 and T1, a baseline Neck Disability Index (NDI) score of 30 or higher, and/or a modified Japanese Orthopaedic Association (mJOA) score of 16 or lower; as well as an inability to respond positively to conservative treatments over the course of 6 weeks since symptom onset or clear signs of nerve root compression or spinal cord damage in spite of continued non-operative care."

Answered by AI

How many participants are currently receiving treatment in this experiment?

"Affirmative. Clinicaltrials.gov confirms that as of April 25th, this medical trial is actively seeking volunteers for participation. Since it's posting on March 7th 2022, the study has been looking to enroll 50 people from two distinct locations."

Answered by AI

Are there currently openings for people to join this experiment?

"The latest information available on clinicaltrials.gov affirms that this trial is actively recruiting patients, with the initial posting occurring March 7th 2022 and a subsequent update on April 25th of the same year."

Answered by AI
~2 spots leftby Jun 2024